Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

NCT07285668 · clinicaltrials.gov ↗

NA

Phase

SUSPENDED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Protocol Modifications

Conditions

Hematologic Malignancies

Interventions

DEVICE: Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells

Sponsor

University of Wisconsin, Madison